Sunday, March 30, 2008

Advances in the Treatment of Gerd in the Elderly

Some age-related pharmacokinetic effects on the organic process of PPIs have been noted in the elderly.
Klotz recently compared published pharmacokinetic data for four PPIs in Brigham Young and elderly populations and found notable increases in half-life and decreases in interval in elderly patients treated with omeprazole, lansoprazole or rabeprazole.
Indeed, the area under the plasm concentration-time shape (AUC) for most PPIs increases by up to 50-100%, reflecting decreasing ECF headway associated with increasing age. In line, the pharmacokinetics of pantoprazole seemed to be freelancer of the patients’ age.
A size memorizer in 14 healthy elderly volunteers indicated that the AUC and Cmax of esomeprazole are also relatively unaffected by age.

A alteration in state of matter license theoretically effectuation that, in general officer, elderly patients require lower dosages of PPIs than younger individuals to achieve the desired stratum of acid organic process.
However, in knowledge indefinite quantity adjustments of PPIs are generally not necessary in the elderly. When comorbidities are involved, the medication regimen should be tailored to the someone case, and should take into profit concomitant illnesses and therapies and any federal agency impairments that may potentially alter the efficacy or tolerability of the medicinal drug PPI.
This is a part of article Advances in the Treatment of Gerd in the Elderly Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

Labels:

Tuesday, March 25, 2008

Regimens for the Eradication of Helicobacter Pylori

Various regimens ranging from 3 days to 8 weeks or more have been evaluated in H pylori eradication, and there seems to be no consensus on the most appropriate continuance.
A meta-analysis of 13 studies compared 7-day, 10-day, and 14-day period of time using a PPI, clarithromycin, and either amoxicillin or metronidazole. Fourteen-day therapies were significantly punter (7% to 9% shift in cure rates) as compared with 7-day therapies (cure rates of 75% to 80%).
Comparisons of 7-day vs 10-day and 10-day vs 14-day regimens showed a nonsignificant discernment toward goodness cure rates with longer therapies.
On the other hand, a meta-analysis of 66 studies evaluating 132 different medicament combinations did not reveal any disagreement in eradication rates with gaze to length of communicating.

Equally high efficacy of 4-day, 7-day, and 10-day base hit therapies was shown by a recent double-blind examination in 76 patients with H pylori-associated ulcers, whereas lower cure rates were seen in a 7-day regimen as compared with a 14-day regimen.

Another recent knowledge domain in patients with endoscopically proven H pylori-positive duodenal ulcers showed that 3-day therapy with RBC plus amoxicillin plus clarithromycin plus metronidazole achieved an eradication rate of 95%.
Another “quadruple” therapy regimen (omeprazole, amoxicillin, tinidazole, and bismuth subcitrate) did not achieve a cure rate of 90%. On the other hand, 5-day quadruplet regimen (rabeprazole, amoxicillin, clarithromycin, and metronidazole) was Lake Superior to 7-day three-base hit therapy (rabeprazole, amoxicillin, and clarithromycin), with eradication rates of 93% (95% CI = 84% to 97%) and 81% (95% CI = 71% to 89%; P < .05), respectively. Short-term quadruplet therapies have also been shown to be effective, safe, and easy to follow in other studies. More meta-analyses are perhaps required to clarify the position of short-term regimens as well as to optimize the period of tending.
This is a part of article Regimens for the Eradication of Helicobacter Pylori Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

Labels:

Saturday, March 15, 2008

Treatment for Acid-Related Disorders

Omeprazole, lansoprazole, pantoprazole, and rabeprazole are substituted benzimidazoles that act to inhibit gastric acid biological process by covalently attractiveness to the proton pump (H+/K+ ATPase), the test common tract for acid body fluid. The PPIs are secreted in the canalicular luminous flux unit of the parietal cell, where they are concentrated and activated by redemption to sulfonamides in the acid state of affairs.
Although rabeprazole is activated at a higher pH, it may be less acid stable than the other PPIs. In their activated form, PPIs bind to cysteine residues in a subunit of the proton pump and inhibit acid humor into the canalicular lm.

All four PPIs bind to the cysteine matter, which is crucial for inhibiting the proton pump.
However, omeprazole, lansoprazole, and rabeprazole bind to additional cysteine residues that do not appear to be related to the medicine acid-inhibiting import of these agents. Whether pantoprazole’s selective protection to the acid-inhibiting cysteine residuum is pharmacodynamically important is animate thing investigated.
Omeprazole, lansoprazole, and pantoprazole bind irreversibly to the gastric proton pump, requiring chemical action of new pumps or start of resting pumps. The protective cover of rabeprazole has been shown in vitro to be partially reversible; however, the clinical grandness of this measuring has yet to be determined. Because PPIs inhibit only actively secreting proton pumps, gastric acid ontogeny is optimal when the PPI is taken about 30 minutes before a meal.

All four PPIs, when given orally within the therapeutic dosing parcel, dose-dependently inhibit basal and stimulated acid bodily fluid, resulting in an gain in both the magnitude and time of acid prohibition. No substantial fluctuation is apparent among the four PPIs in increasing gastrin concentrations.
This is a part of article Treatment for Acid-Related Disorders Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

Labels:

Monday, March 10, 2008

Effects of Lansoprazole and Rabeprazole

The acid inhibitory outcome of both lansoprazole and rabeprazole were strongly dose dependent.
The effects of lansoprazole were greater than those of rabeprazole for up to the first gear 5 hour after both unity and repeated doses, but generally less from the eleventh hour onwards.
The faster military operation of deed of lansoprazole is unlikely to be important in long-term discussion, but might give an welfare over rabeprazole at the advantage of symptomatic aid.
In this knowledge domain, the conventional pharmacodynamic abstract entity of pct time for pH >4 discriminated more powerfully among discussion regimens than did integrated gastric pH.
This is a part of article Effects of Lansoprazole and Rabeprazole Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

Labels: